Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study

Abstract

Tumor 3DVGR could be helpful to detect early signal of drugs antitumoral activity or nonactivity. This volume response classification could help in the assessment of drug activity in tumors with mostly volume stabilization and rare response as aggressive meningiomas even with a low number of patients in complement to 6 months PFS.